IBSRELA FDA approval date

The FDA approved IBSRELA on 12 Sep 2019.

FDA approval date
12 Sep 2019

Drug identity has not yet been verified against registry records

Also recorded as TENAPANOR HYDROCHLORIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2019-09-12DayIBSRELAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA211801", "applicant_as_listed_by_fda": "ARDELYX INC", "brand_names": ["IBSRELA"], "active_ingredients": ["TENAPANOR HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20190912", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026